OUR APPROACH
Why our model matters.
Most cancer research funding goes to projects that are short-term or incremental. At CBCF, we fund bold, transformative science—the kind that challenges assumptions and accelerates discovery.
Guided by scientific leadership.
All of our research funding is directed under the leadership of Dr. Larry Norton at Memorial Sloan Kettering Cancer Center, in collaboration with leading researchers worldwide. His vision and expertise ensure we invest in the most promising ideas with the greatest potential to change patient outcomes.
How we fund.
- Recommendations – Dr. Norton and his collaborators identify groundbreaking projects that could shift the field
- Review – Each project is assessed for both scientific rigor and potential impact, with input from trusted advisors.
- Approval – CBCF’s Board of Trustees evaluates recommendations and approves funding to ensure alignment with our mission and responsible stewardship of donor dollars.
Expanding Impact Through Strategic Innovation
Investing in the future of cancer research.
CBCF invests in early-stage oncology technologies to turn breakthrough ideas into real-world treatments.
In addition to making grants for groundbreaking research, CBCF strategically invests in early-stage technologies in oncology. These investments help bridge the gap between scientific discovery and clinical impact, ensuring that promising ideas have the resources to move from the lab toward patient benefit.
Any financial returns are reinvested directly into our mission, amplifying the impact of every donor dollar and sustaining the cycle of innovation that brings us closer to a cure.
Direct Impact, Lasting Results.
Because we operate with a lean structure, donor dollars flow directly into research. This means your gift isn’t diluted and goes straight to funding discoveries that can change how the world understands and treats breast cancer.
Your Gift Makes Research Possible
Every gift moves pioneering research forward—advancing discoveries that save lives and shaping the future of breast cancer care.